Mass Genomics's Dan Koboldt rounds up a recent cancer genomics meeting in St. Louis, which included talks from Peter Campbell, Richard Gibbs, and Elaine Mardis, among others. Campbell introduced the Wellcome Trust Sanger Institute's first cancer genome; Gibbs spoke about Baylor's multiple-platform approach to whole genome sequencing; and Mardis gave an overview of the strategies being used at Washington University to use next-gen sequencing to study cancer genomes.